PTPRN2 and tauopathy: Because we did not generate an alternative targeted insertion of a tTA transgene for our current work, we cannot determine if the loss of the genes disrupted by the Vipr2-Ptprn2 tTA-TgINDEL directly affect the tauopathy phenocopy of rTg4510.